What are the complication rates of ultrasound-guided thoracentesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Complication Rates of Ultrasound-Guided Thoracentesis

Ultrasound-guided thoracentesis has a very low complication rate, with pneumothorax occurring in approximately 3.8% of cases (38 per 1,000 procedures), bleeding in approximately 0.3% (3 per 1,000), and only 0.6% (6 per 1,000) requiring chest tube placement. 1

Major Complications

Pneumothorax

  • Incidence: 3.8% (38/1,000 procedures) with ultrasound guidance 1
  • Only 0.6% (1 in 170 procedures) require chest tube decompression 2
  • Of patients who develop pneumothorax, only 1 in 6 actually need a chest tube 2
  • Real-time ultrasound guidance by trained intensivists shows even lower rates at 1.2% 3

Key risk factors for pneumothorax:

  • Removal of >1,500 mL fluid significantly increases risk 4
  • Multiple needle passes through the skin 4
  • Unilateral procedures (compared to bilateral) 4

Bleeding

  • Incidence: 0.3% (3/1,000 procedures) 1
  • Extremely rare at 0.18-0.2% in large series 4, 5
  • Critical finding: Abnormal coagulation parameters (INR >1.6 or platelets <50×10⁹/L) do NOT increase bleeding risk 6
  • In 1,009 procedures with uncorrected coagulopathy, there were zero bleeding complications (0%), while those who received correction had 1.32% bleeding rate 6

Common pitfall to avoid: Do not routinely correct INR or transfuse platelets before ultrasound-guided thoracentesis—this practice is not evidence-based and may paradoxically increase complications 6.

Re-expansion Pulmonary Edema (REPE)

  • Incidence: 0.01-0.5% 4, 5
  • For every 1 mL of fluid removed, there is a 0.18% increased risk 4
  • Occurs in approximately 0.5% when >1,000 mL removed 5
  • Prevention strategy: Stop the procedure immediately when patient develops symptoms (chest discomfort, cough, dyspnea) during drainage 5

Minor Complications

  • Pain: 2.7% (increased when >1,100 mL removed) 5
  • Vasovagal reactions: 0.6% (prophylactic atropine is unnecessary) 5
  • Shortness of breath: 1.0% 5
  • Cough: 0.8% 5

Clinical Context and Comparison

The 2023 British Thoracic Society guideline strongly recommends image-guided thoracentesis should always be used because it reduces pneumothorax risk from 50/1,000 (non-guided) to 38/1,000 (image-guided) and improves successful fluid sampling from 782/1,000 to 1,000/1,000 1. This represents a 24% relative risk reduction in pneumothorax.

Important Clinical Indicators

Symptomatic pneumothorax warning signs:

  • 57% of patients with shortness of breath during the procedure had pneumothorax on post-procedure imaging 5
  • Only 16% of patients with pain had pneumothorax 5
  • Only 6.7% of post-procedural pneumothoraces caused documented symptom changes 2

Practical Implications

The overall complication rate requiring intervention is remarkably low at 0.6-0.8% for chest tube placement 2, 4. The evidence demonstrates that ultrasound-guided thoracentesis performed by trained personnel is exceptionally safe, with a total serious complication rate well under 1% 3, 4, 6, 5.

The procedure shows significant improvement in oxygenation post-procedure (mean PaO₂/FiO₂ increased from 198 to 225, p<0.05) 3, supporting its therapeutic benefit with minimal risk.

Related Questions

When should a diagnostic thoracentesis be performed?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
In ischemic priapism caused by phosphodiesterase type 5 (PDE5) inhibitors, is the glans penis spared?
Which vitamins can a generally healthy adult take to prevent the common cold?
What are the possible causes of marked redness and hypersensitivity of the penis (especially the glans) in a patient with PDE‑5 inhibitor–induced priapism?
I am a circumcised male who took daily tadalafil (Cialis) 5 mg for two weeks, then a 10 mg dose, and the same night took 60 mg sildenafil (Viagra) chew, after which I experienced a prolonged erection with persistent firmness, glans discoloration, numbness, and a dull ache; one month later these symptoms persist. What is the expected healing timeline?
What is the recommended treatment for seronegative autoimmune autonomic ganglionopathy (autoimmune autonomic neuropathy)?
If a random cortisol level is normal, can a patient still have Addison's disease (primary adrenal insufficiency)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.